From Investment to Impact: The ROI of Tailored Obesity Care

  • Case Study
  • Obesity care and GLP-1s

Summary

As organizations seek solutions to combat the rising costs associated with obesity, attention has turned to promising new treatments such as GLP-1s.  However, implementing these therapies is not without its challenges; foremost among them is the extraordinarily high cost of these medications in the United States. 

For organizations who still want to cover brand name GLP-1 medications while effectively mitigating costs, Noom Med offers a revolutionary solution that pairs biology and psychology to rightsize GLP-1 use, drive better outcomes, and lower overall costs. 

Offering a compelling projected 4.1X ROI for an organization with 20,000 employees, Noom Med addresses the root of the problem — uncontrolled healthcare spending — while improving employee health outcomes. 

Download the ROI breakdown to learn how Noom Med slashes unnecessary costs while also ensuring that GLP-1 medications are used optimally, maximizing their benefits while minimizing waste. 

Effective weight loss with Noom, focusing on personalized obesity care to improve ROI through tailored health strategies.

Download the Free Report

By submitting this form, I understand that Noom will process my personal information in accordance with their Privacy Policy.

Bring Noom to
your organization

Give your workforce a preview of what’s possible
for their physical and mental health.